Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.480 +0.020 (+1.37%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Dow Rises Over 100 Points; Revelation Biosciences Shares Spike Higher ↗

July 25, 2022

U.S. stocks traded mostly higher midway through trading on Monday.

Via Benzinga

Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session ↗

July 25, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.

Via Benzinga

Why U.S. Stocks Are Trading Mostly Higher; Chicago Fed National Activity Index Remains Unchanged ↗

July 25, 2022

U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 100 points on Monday.

Via Benzinga

Enveric Biosciences Stock Is Nosediving Today: What's Happening? ↗

July 25, 2022

Enveric Biosciences Inc (NASDAQ: ENVB) shares are trading lower by 21.84% to $7.55 Monday morning after the company announced an $8 million registered direct offering and private placement.

Via Benzinga

Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact ↗

July 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

11 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 25, 2022

Via Benzinga

Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules

July 25, 2022

From Enveric Biosciences, Inc.

Via Business Wire

This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday ↗

July 25, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 22, 2022

Via Benzinga

Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines

July 19, 2022

From Enveric Biosciences, Inc.

Via Business Wire

The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate ↗

July 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 14, 2022

Via Benzinga

Enveric Biosciences Announces Reverse Stock Split

July 14, 2022

From Enveric Biosciences, Inc.

Via Business Wire

Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday ↗

July 15, 2022

Gainers

Via Benzinga

Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market ↗

July 13, 2022

Article by Jason Najum. Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the...

Via Benzinga

Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio

July 13, 2022

From Enveric Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 12, 2022

Via Benzinga

Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session ↗

July 11, 2022

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 11, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 30, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 28, 2022

Via Benzinga

10 Psychedelics CEOs To Pay Attention To In 2022 ↗

June 22, 2022

By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both...

Via Benzinga

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗

June 30, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022 ↗

June 01, 2022

Upgrades

Via Benzinga

Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗

May 17, 2022

The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 11, 2022

Via Benzinga

EXCLUSIVE: NASDAQ-Listed Enveric To Split Into Two Companies, One For Cannabinoids, One For Psychedelics ↗

May 11, 2022

Enveric Biosciences (NASDAQ: ENVB), a biotech company working with cannabinoids and psychedelics, announced it will spin off its cannabinoid pipeline into a separate public company that will also be...

Via Benzinga

American Billionaire Entrepreneurs Bet Millions on Psychedelics

May 10, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...

Via FinancialNewsMedia

Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved ↗

April 25, 2022

Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...

Via Benzinga

Missed The Benzinga Psychedelics Capital Conference? Check Out Full Recording And Exclusive Coverage ↗

April 25, 2022

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.